192 related articles for article (PubMed ID: 31119568)
1. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
[TBL] [Abstract][Full Text] [Related]
2. Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis.
Mohankumar K; Li X; Sung N; Cho YJ; Han SJ; Safe S
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32099996
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
[TBL] [Abstract][Full Text] [Related]
4. Bis-Indole-Derived NR4A1 Ligands and Metformin Exhibit NR4A1-Dependent Glucose Metabolism and Uptake in C2C12 Cells.
Mohankumar K; Lee J; Wu CS; Sun Y; Safe S
Endocrinology; 2018 May; 159(5):1950-1963. PubMed ID: 29635345
[TBL] [Abstract][Full Text] [Related]
5. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.
Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035
[TBL] [Abstract][Full Text] [Related]
6. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200
[TBL] [Abstract][Full Text] [Related]
7. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.
Lee SO; Li X; Hedrick E; Jin UH; Tjalkens RB; Backos DS; Li L; Zhang Y; Wu Q; Safe S
Mol Endocrinol; 2014 Oct; 28(10):1729-39. PubMed ID: 25099012
[TBL] [Abstract][Full Text] [Related]
8. The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.
Hedrick E; Lee SO; Safe S
Mol Carcinog; 2017 Sep; 56(9):2066-2075. PubMed ID: 28418095
[TBL] [Abstract][Full Text] [Related]
9. Targeting NR4A1 (TR3) in cancer cells and tumors.
Lee SO; Li X; Khan S; Safe S
Expert Opin Ther Targets; 2011 Feb; 15(2):195-206. PubMed ID: 21204731
[TBL] [Abstract][Full Text] [Related]
10. Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.
Mohankumar K; Li X; Sridharan S; Karki K; Safe S
Gynecol Oncol; 2019 Jul; 154(1):218-227. PubMed ID: 31053403
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma.
Hedrick E; Lee SO; Kim G; Abdelrahim M; Jin UH; Safe S; Abudayyeh A
PLoS One; 2015; 10(6):e0128308. PubMed ID: 26035713
[TBL] [Abstract][Full Text] [Related]
12. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells.
Lee SO; Jin UH; Kang JH; Kim SB; Guthrie AS; Sreevalsan S; Lee JS; Safe S
Mol Cancer Res; 2014 Apr; 12(4):527-538. PubMed ID: 24515801
[TBL] [Abstract][Full Text] [Related]
13. Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands.
Upadhyay S; Hailemariam AE; Mariyam F; Hafiz Z; Martin G; Kothari J; Farkas E; Sivaram G; Bell L; Tjalkens R; Safe S
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540704
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.
Lee SO; Abdelrahim M; Yoon K; Chintharlapalli S; Papineni S; Kim K; Wang H; Safe S
Cancer Res; 2010 Sep; 70(17):6824-36. PubMed ID: 20660371
[TBL] [Abstract][Full Text] [Related]
15. A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity.
Karki K; Wright GA; Mohankumar K; Jin UH; Zhang XH; Safe S
Cancer Res; 2020 Mar; 80(5):1011-1023. PubMed ID: 31911554
[TBL] [Abstract][Full Text] [Related]
16. 1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model.
Andey T; Patel A; Jackson T; Safe S; Singh M
Eur J Pharm Sci; 2013 Oct; 50(2):227-41. PubMed ID: 23892137
[TBL] [Abstract][Full Text] [Related]
17. NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor Growth.
Karki K; Mohankumar K; Schoeller A; Martin G; Shrestha R; Safe S
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072371
[TBL] [Abstract][Full Text] [Related]
18. The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells.
Shrestha R; Mohankumar K; Jin UH; Martin G; Safe S
Mol Cancer Ther; 2021 Mar; 20(3):612-622. PubMed ID: 33277444
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.
Mohankumar K; Shrestha R; Safe S
Mol Carcinog; 2022 Jan; 61(1):73-84. PubMed ID: 34699643
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.
Karki K; Li X; Jin UH; Mohankumar K; Zarei M; Michelhaugh SK; Mittal S; Tjalkens R; Safe S
J Neurooncol; 2020 Jan; 146(1):25-39. PubMed ID: 31754919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
